MedTrace Logo

Laparoscopic Sleeve Gastrectomy: a Cohort Study

NCT03629808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2020-04-22

No results posted yet for this study

Summary

This is a prospective cohort study, which subjects were obese patients requiring LSG surgery. LSG with different gastric resection starting points (2-4cm/4-6 cm from pylorus) as intervention method. The main observation is the incidence and extent of upper gastrointestinal symptoms (such as nausea, vomiting, retching, reflux, difficulty swallowing, etc.).In addition, secondary observations include the excess weight loss (%EWL) and postoperative complications. Aim to investigate the effects of LSG surgery in different starting points of gastric resection on postoperative upper gastrointestinal symptoms.

Conditions

  • Laparoscopic Sleeve Gastrectomy

Interventions

PROCEDURE

4-6cm from starting point of gastrectomy to pylorus

The starting point of gastrectomy of the distance from the pylorus is 4-6cm during operative.

PROCEDURE

2-4cm from starting point of gastrectomy to pylorus

The starting point of gastrectomy of the distance from the pylorus is 2-4cm during operative.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER

  • Beijing Tiantan Hospital

    collaborator OTHER

  • Beijing Hospital

    collaborator OTHER_GOV

  • Beijing Shijitan Hospital, Capital Medical University

    collaborator OTHER

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Zhongtao Zhang · Beijing Friendship Hospital

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-10
Primary Completion
2020-03-28
Completion
2020-04-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03629808 on ClinicalTrials.gov